ATG16L1 and lung adenocarcinoma: As shown in Table 1, ATG10 rs10036653, ATG12 rs26538, ATG16L1 rs2241880 and ATG16L2 rs11235604 were significantly associated with OS of gefitinib-treated advanced lung adenocarcinoma patients (all P < 0.05).